back to the latest
February 5, 2026

Over 61% Reduction in Sick Leave After a Single Intervention?

Following the implementation of Resysten’s antimicrobial surface treatment at the National Energy Agency, the rate of sick leave dropped by more than half.

Following the implementation of Resysten’s antimicrobial surface treatment at the National Energy Agency, the rate of sick leave dropped by more than half.

The technology is invisible – but the results are impossible to miss:

Dramatic reduction in illness rates

Increased productivity: fewer sick days mean fewer workflow disruptions

Improved availability: fewer illnesses lead to fewer unexpected shutdowns

Stronger employer branding: A responsible, future-oriented, health-conscious employer image boosts employee commitment and loyalty

Date of implementation: July 2023

Evaluation period: July 2023 – May 2025

Reduction achieved: 61.14%

Location: National Energy Agency

Don’t wait any longer! Boost your efficiency while saving costs!

Invest in prevention – it’s a proven return on investment!